drugset / Trial / NCT04505501
Reducing HIV Persistence in Lymph Nodes by Interleukin-15 (IL-15) Receptor Super-agonist (N-803) in Acute HIV Infection
Phase 2
Active not recruiting
14 enrolled
Thai Red Cross AIDS Research Centre
Henry M. Jackson Foundation for the Advancement of Military Medicine · collabWalter Reed Army Institute of Research (WRAIR) · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
Reducing HIV persistence in lymph nodes by Interleukin-15 (IL-15) Receptor super-agonist (N-803) in Individuals with Acute HIV Infection
Timeline
- Start
- 2021-03-01
- Primary completion
- 2025-06-30
- Completion
- 2025-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | N-803 | Protein / enzyme biologic | 6 ug/kg | Subcutaneous |